No Data
No Data
No Data
No Data
No Data
Rubius Therapeutics To Go Ex-Dividend On January 2nd, 2024 With 0.05794 USD Dividend Per Share
December 27th - $Rubius Therapeutics(RUBY.US)$ is trading ex-dividend on January 2nd, 2024. Shareholders of record on December 26th, 2023 will receive 0.05794 USD dividend per share on December 29
Futu NewsDec 27, 2023 08:55
Rubius Therapeutics (NASDAQ:RUBY) and Vigil Neuroscience (NASDAQ:VIGL) Critical Survey
Rubius Therapeutics (NASDAQ:RUBY – Get Rating) and Vigil Neuroscience (NASDAQ:VIGL – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two busin
Financial News LiveApr 20, 2023 16:25
Head to Head Analysis: Rubius Therapeutics (NASDAQ:RUBY) Versus Vigil Neuroscience (NASDAQ:VIGL)
Rubius Therapeutics (NASDAQ:RUBY – Get Rating) and Vigil Neuroscience (NASDAQ:VIGL – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two busines
Defense WorldApr 16, 2023 13:32
National Bank Presents List of ETFs to Help Investors Monitor Market Situation
12:09 PM EDT, 03/15/2023 (MT Newswires) -- National Bank on Tuesday presented a list of exchange-traded funds that investors can use to monitor the rapidly evolving situation amid the collapse of the
MT NewswiresMar 16, 2023 00:11
Rubius Therapeutics, Inc. (NASDAQ:RUBY) Sees Large Increase in Short Interest
Rubius Therapeutics, Inc. (NASDAQ:RUBY – Get Rating) was the recipient of a significant increase in short interest in February. As of February 28th, there was short interest totalling 2,800,000 shares
kopsourceMar 12, 2023 04:04
Cardiol Therapeutics (NASDAQ:CRDL) & Rubius Therapeutics (NASDAQ:RUBY) Critical Survey
Rubius Therapeutics (NASDAQ:RUBY – Get Rating) and Cardiol Therapeutics (NASDAQ:CRDL – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companie
Defense WorldMar 9, 2023 14:04
No Data
No Data